Piramal Healthcare Ltd.
 
Bse Code: 500302 | NSE CODE: PIRHEALTH | Sector: Pharmaceuticals & Drugs
Prev Close
Open
MarketCap(` in Cr.)
Volume (No. of shares)
52 W LOW
52 W HIGH
LOW
HIGH

price chart

News

Piramal Healthcare has agreed to buy a U.S.-based healthcare data provider for $635 million to boost research and developmen...
Ajay Piramal today said the investment in Vodafone is not a strategic one.

financial summary

` in Cr.MAR 2011MAR 2010yoy(%)
Net Sales1,585.362,650.94-40.20
Total Expenditure1,567.942,072.52-24.35
Operating Profit514.71726.20-29.12
Interest79.79156.36-48.97
PBDT434.92569.84-23.68
Depreciation77.6192.22-15.84
PAT12,896.91443.222,809.82

Research

No Research found.

Ratios

Earnings Per Share (Rs)768.13
Book NAV by Share(Rs)696.75
EBIT Margin(%)1,031.52
PAT Margin (%)799.15
ROCE(%)235.35
Price by Book(x)0.60
Yield(%)2.88
PAT Growth(%)2,809.82
Total Debt by Equity(x)0.02

More About this company on NDTV Profit

No Interviews/Opinions found.

announcement / Events


Dateannouncement / events
May 03, 2012
03:37 PM
Announces Q4 & FY12 results & Results Press Release for the period March 31, 2012
May 03, 2012
03:39 PM
Board recommends Dividend
May 03, 2012
03:51 PM
Fixes Book Closure for Dividend & AGM
May 16, 2012
10:34 AM
Piramal Healthcare Limited to Acquire Decision Resources Group

shareholding pattern

DescriptionPercent of Share(%)
Total Promoter53.31
Govt0.00
FII20.80
Institutions26.74

Corporate Information

N Santhanam
NA
Keki Dadiseth
Director
Rajesh Laddha
Chief Financial Officer
 
Registered Office:
Piramal Tower
Ganpatrao Kadam Marg,
Mumbai,Maharashtra.
Tel : +91-22-30466666
Fax : +91-22-24902363
 
Registrars Details:
Link Intime India Pvt Ltd
C-13 Pannalal Silk Compound,
L B S Marg,
Bhandup,
Mumbai

peer companies

CompanyPRICE (`) 
Sanofi India Ltd.
2,114.80-0.29
Astrazeneca Pharma India Ltd.
1,894.905.05
Abbott India Ltd.
1,454.20-0.73
Pfizer Ltd.
1,197.650.19
Strides Arcolab Ltd.
697.350.48

MARKETS

TOP VIDEO

46:26